Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661970 · ClinicalTrials.gov registry record
Cochlear Implant Speech and Non-speech Sound Recognition
A clinical trial, sponsored by Pacific Northwest University of Health Sciences.
- Terminated
- Registry status
- 10
- Enrollment target
NCT03661970: Clinical Trial study, sponsored by Pacific Northwest University of Health Sciences.
NCT03661970 is a clinical trial that was terminated before completion, run by Pacific Northwest University of Health Sciences. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03661970 was terminated before completion, sponsored by Pacific Northwest University of Health Sciences.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary purpose of the research is to study how synthesized speech and non-speech percepts (sounds) are recognized in subjects with cochlear implants (CI) who are not getting functional speech recognition using existing speech to CI algorithms. By identifying a partial set of phonemes (units of speech) from this CI feedback, a new language could be developed.
Primary Outcome
Self reported detection and differentiation of sounds generated by the Cognate Speech Synthesizer.
Interventions
- OTHER Cognate Speech Synthesizer sound percepts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-06-10 |
| Est. Completion | 2023-04-20 |
Why NCT03661970 stopped before completion
NCT03661970 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cognate Speech Synthesizer sound percepts is the first listed.
NCT03661970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03661970 about?
NCT03661970 is a clinical study titled "Cochlear Implant Speech and Non-speech Sound Recognition". The primary purpose of the research is to study how synthesized speech and non-speech percepts (sounds) are recognized in subjects with cochlear implants (CI) who are not getting functional speech recognition using existing speech to CI algorithms. By identifying a partial set of phonemes (units of ...
What is the current status of trial NCT03661970?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2018-06-10. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT03661970?
The interventions under investigation include: Cognate Speech Synthesizer sound percepts (OTHER).
Who is sponsoring clinical trial NCT03661970?
This trial is sponsored by Pacific Northwest University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI